Edwards Lifesciences

CompanyUnited States

Edwards Lifesciences develops 5 assets, the furthest in human trials (Edwards APTURE transcatheter shunt system in heart failure). Mostly device; based in the United States.

Assets
5
Furthest
Human trials
Trials
3
Signals
1

Pipeline

5

  • Edwards APTURE transcatheter shunt system

    Transcatheter shunt system to treat symptomatic heart failure patients with elevated left atrial pressure

    Human trialsDeviceheart failure

  • INSPIRIS RESILIA Aortic Valve

    Bovine pericardial tissue aortic valve with anti-calcification RESILIA tissue technology.

    Human trialsDeviceaortic valve replacement

  • KONECT RESILIA AVC

    Pre-assembled aortic valved conduit with anti-calcification tissue technology for aortic valve replacement.

    Human trialsDeviceaortic valve disease

2 more assets

Full company profiles: pipeline, trials, funding and people.

See Pro
  • Trials4
  • Signals1
  • Integrity notices1
  • Similar companies6

Updated 7 Oct 2026 · 13 sources

Intelligence